Mark HaLi G.

Institutional Business Manager at Rigel Pharmaceuticals Inc.
  • Claim this Profile
Contact Information
Location
Elgin, Illinois, United States, US

Topline Score

Bio

Generated by
Topline AI

0

/5.0
/ Based on 0 ratings
  • (0)
  • (0)
  • (0)
  • (0)
  • (0)

Filter reviews by:

No reviews to display There are currently no reviews available.

0

/5.0
/ Based on 0 ratings
  • (0)
  • (0)
  • (0)
  • (0)
  • (0)

Filter reviews by:

No reviews to display There are currently no reviews available.
You need to have a working account to view this content. Click here to join now

Credentials

  • How to Speak So People Want to Listen
    LinkedIn
    Sep, 2022
    - Sep, 2024
  • The Six Biases of Decision-Making
    LinkedIn
    Sep, 2022
    - Sep, 2024
  • CITI Good Clinical Practice
    CITI Program
    Feb, 2022
    - Sep, 2024
  • Biomedical Research Certification
    CITI Program
    Jan, 2022
    - Sep, 2024

Experience

    • United States
    • Biotechnology Research
    • 100 - 200 Employee
    • Institutional Business Manager
      • Jul 2023 - Present
    • United States
    • Biotechnology
    • 100 - 200 Employee
    • Medical Science Liaison
      • Dec 2020 - Mar 2023

      Support new drug and clinical trial development & maturation, collaborating with national and global key opinion leaders and relevant stakeholders to advance medical information discovery and exchange.

    • Associate Director of Marketing
      • Aug 2020 - Dec 2020

    • Clinical Science Specialist
      • Apr 2020 - Aug 2020

    • Events Services
    • 1 - 100 Employee
    • Senior Oncology Account Specialist
      • Feb 2018 - Apr 2020

      Supported major institutions consulting on important information about Pfizer’s Oncology Lung, Renal, immuno-oncology, biosimilar and breast franchise medications. Supported major institutions consulting on important information about Pfizer’s Oncology Lung, Renal, immuno-oncology, biosimilar and breast franchise medications.

    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Senior Oncology Portfolio Specialist
      • Oct 2014 - Sep 2017

      Served Maryland-based oncology healthcare systems and other HCPs with an interest in cancer by establishing and cultivating access to pharmaceutical solutions for the treatment of mBreast Ca & Soft Tissue Sarcoma (Halaven-IV), Thyroid, Renal Cell Carcinoma & Hepatocellular Ca (Lenvima-PO) and CINV (Akynzeo-PO & Aloxi-IV). Served Maryland-based oncology healthcare systems and other HCPs with an interest in cancer by establishing and cultivating access to pharmaceutical solutions for the treatment of mBreast Ca & Soft Tissue Sarcoma (Halaven-IV), Thyroid, Renal Cell Carcinoma & Hepatocellular Ca (Lenvima-PO) and CINV (Akynzeo-PO & Aloxi-IV).

    • United States
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Senior Hematology Sales Specialist
      • Jul 2013 - Oct 2014

      Served institutions and community HCPs throughout Northern Manhattan, Bronx and Nyack. Expanded appropriate utilization of Velcade-IV as a valuable treatment option for Multiple Myeloma. Served institutions and community HCPs throughout Northern Manhattan, Bronx and Nyack. Expanded appropriate utilization of Velcade-IV as a valuable treatment option for Multiple Myeloma.

    • France
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Corporate Office Global Trainer / Oncology Key Account Lead etc.
      • Aug 2002 - Jul 2013

      Designed and facilitated strategic adult learning curriculum for commercial teams globally in support of the oncology/hematology multi-billion-dollar product portfolio [Eloxatin-IV (CRC), Taxotere-IV (multi-indications), Lovenox-Sub-Q (coagulation disorders), Elitek-IV (TLS) & Jevtana-IV (Prostate)]. Designed and facilitated strategic adult learning curriculum for commercial teams globally in support of the oncology/hematology multi-billion-dollar product portfolio [Eloxatin-IV (CRC), Taxotere-IV (multi-indications), Lovenox-Sub-Q (coagulation disorders), Elitek-IV (TLS) & Jevtana-IV (Prostate)].

    • United States
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Oncology Sales Consultant / Trainer - Territory Analytics
      • Jul 2001 - Sep 2002

      Introduced and established Daiichi Pharmaceuticals to the oncology community throughout Manhattan, Westchester and Bronx, NY. Introduced and established Daiichi Pharmaceuticals to the oncology community throughout Manhattan, Westchester and Bronx, NY.

    • United Kingdom
    • 1 - 100 Employee
    • Clinical Sales Specialist
      • Dec 1999 - Jul 2001

      Initiated and cultivated relationships with HIV/AIDS physicians, pharmacists and key decision-makers in hospitals, managed care and community medical organizations in Manhattan. Initiated and cultivated relationships with HIV/AIDS physicians, pharmacists and key decision-makers in hospitals, managed care and community medical organizations in Manhattan.

Education

  • Thomas Jefferson University
    Doctor of Health Science, Population Health
    2021 - 2024
  • New York University
    Master's degree, Public Health
    2018 - 2024
  • Georgia Tech Scheller College of Business
    MBA, Global Business
    2006 - 2008
  • Winthrop University
    BS, Finance
    1989 - 1993

Community

You need to have a working account to view this content. Click here to join now